|
|
||||||||
,11UCD Diabetes Research Centre, School of Biomolecular and Biomedical Science; and 2Medicine and Medical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland
Submitted 20 November 2007 ; accepted in final form 15 May 2008
The molecular pathogenesis of diabetic nephropathy (DN), the leading cause of end-stage renal disease worldwide, is complex and not fully understood. Transforming growth factor-β (TGF-β1) plays a critical role in many fibrotic disorders, including DN. In this study, we report protein kinase B (PKB/Akt) activation as a downstream event contributing to the pathophysiology of DN. We investigated the potential of PKB/Akt to mediate the profibrotic bioactions of TGF-β1 in kidney. Treatment of normal rat kidney epithelial cells (NRK52E) with TGF-β1 resulted in activation of phosphatidylinositol 3-kinase (PI3K) and PKB/Akt as evidenced by increased Ser473 phosphorylation and GSK-3β phosphorylation. TGF-β1 also stimulated increased Smad3 phosphorylation in these cells, a response that was insensitive to inhibition of PI3K or PKB/Akt. NRK52E cells displayed a loss of zona occludins 1 and E-cadherin and a gain in vimentin and
-smooth muscle actin expression, consistent with the fibrotic actions of TGF-β1. These effects were blocked with inhibitors of PI3K and PKB/Akt. Furthermore, overexpression of PTEN, the lipid phosphatase regulator of PKB/Akt activation, inhibited TGF-β1-induced PKB/Akt activation. Interestingly, in the Goto-Kakizaki rat model of type 2 diabetes, we also detected increased phosphorylation of PKB/Akt and its downstream target, GSK-3β, in the tubules, relative to that in control Wistar rats. Elevated Smad3 phosphorylation was also detected in kidney extracts from Goto-Kakizaki rats with chronic diabetes. Together, these data suggest that TGF-β1-mediated PKB/Akt activation may be important in renal fibrosis during diabetic nephropathy.
diabetic nephropathy; transforming growth factor-β1
This article has been cited by other articles:
![]() |
G. Zheng, J. G. Lyons, T. K. Tan, Y. Wang, T.-T. Hsu, D. Min, L. Succar, G. K. Rangan, M. Hu, B. R. Henderson, et al. Disruption of E-Cadherin by Matrix Metalloproteinase Directly Mediates Epithelial-Mesenchymal Transition Downstream of Transforming Growth Factor-{beta}1 in Renal Tubular Epithelial Cells Am. J. Pathol., August 1, 2009; 175(2): 580 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Roxburgh, J. J. Kattla, S. P. Curran, Y. M. O'Meara, C. A. Pollock, R. Goldschmeding, C. Godson, F. Martin, and D. P. Brazil Allelic Depletion of grem1 Attenuates Diabetic Kidney Disease Diabetes, July 1, 2009; 58(7): 1641 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Gayer, L. S. Chaturvedi, S. Wang, D. H. Craig, T. Flanigan, and M. D. Basson Strain-induced Proliferation Requires the Phosphatidylinositol 3-Kinase/AKT/Glycogen Synthase Kinase Pathway J. Biol. Chem., January 23, 2009; 284(4): 2001 - 2011. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |